Zohar Barbash
Chief Technology Officer & Co-Founder LEMBAS
Dr. Zohar Barbash is Co-Founder and CTO at Lembas, pioneering the use of AI to develop novel peptides for weight management and metabolic health. She brings over a decade of biotech and pharma R&D leadership, having previously served as CTO at Wilk, VP of R&D at ForeBio, and VP of R&D at NovellusDX. She completed her postdoctoral training in cancer immunology at the NIH/NCI and holds a Ph.D. from Tel Aviv University.
Seminars
Tuesday 2nd March 2027
Panel Discussion: From AI Adoption to AI Accountability – What Has AI Actually Delivered for GPCR Discovery?
11:00 am
- Where has AI demonstrably delivered measurable impact on GPCR hit identification, optimization and candidate selection?
- What benchmarks and validation frameworks do the field need to credibly assess AI platform performance against traditional methods?
- As AI capabilities expand, where does biological expertise and experimental validation remain non negotiable in the decision-making process?
Thursday 4th March 2027
Applying Iterative Machine Learning to Expand GPCR Therapeutics Beyond GLP-1
12:00 pm
- Demonstrating how internally generated biological data can continuously improve GPCR prediction performance across successive discovery campaigns
- Transferring learnings from GLP-1-focused programs to accelerate discovery against novel intestinal GPCR targets
- Advancing next-generation peptide therapeutics for muscle preservation, metabolic health and post-GLP-1 patient support through AI-enabled discovery
